| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
8,899 |
7,551 |
$807K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
5,558 |
4,734 |
$514K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,131 |
1,845 |
$140K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
287 |
282 |
$31K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
310 |
251 |
$24K |
| 99201 |
|
238 |
222 |
$23K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
241 |
213 |
$20K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
144 |
134 |
$15K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
246 |
230 |
$6K |
| 99381 |
|
57 |
55 |
$6K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
47 |
47 |
$5K |
| 99051 |
|
261 |
260 |
$3K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
24 |
24 |
$3K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
130 |
65 |
$2K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
70 |
62 |
$2K |
| 87428 |
|
31 |
30 |
$1K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
57 |
56 |
$967.60 |
| 99221 |
|
26 |
25 |
$880.50 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
14 |
14 |
$676.06 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
13 |
13 |
$566.93 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
13 |
13 |
$364.00 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
192 |
183 |
$249.16 |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
351 |
325 |
$231.12 |
| 36415 |
Collection of venous blood by venipuncture |
1,129 |
907 |
$209.34 |
| 90670 |
|
445 |
429 |
$110.48 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
916 |
839 |
$3.25 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
14 |
13 |
$0.00 |
| 90698 |
|
92 |
90 |
$0.00 |
| 3074F |
|
532 |
479 |
$0.00 |
| 3044F |
|
34 |
32 |
$0.00 |
| 90723 |
|
220 |
216 |
$0.00 |
| 3008F |
|
783 |
677 |
$0.00 |
| 3079F |
|
178 |
158 |
$0.00 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
58 |
56 |
$0.00 |
| 90686 |
|
58 |
57 |
$0.00 |
| 90647 |
|
217 |
212 |
$0.00 |
| 92551 |
|
94 |
83 |
$0.00 |
| 3075F |
|
55 |
50 |
$0.00 |
| 3080F |
|
14 |
13 |
$0.00 |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
198 |
180 |
$0.00 |
| 1160F |
|
746 |
696 |
$0.00 |
| 90633 |
|
63 |
56 |
$0.00 |
| 3078F |
|
413 |
371 |
$0.00 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
1,011 |
956 |
$0.00 |
| 1159F |
|
1,830 |
1,659 |
$0.00 |
| 99173 |
|
117 |
103 |
$0.00 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
22 |
16 |
$0.00 |
| 3077F |
|
21 |
20 |
$0.00 |